{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T11:56:40Z","timestamp":1771329400118,"version":"3.50.1"},"reference-count":27,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2021,1,5]],"date-time":"2021-01-05T00:00:00Z","timestamp":1609804800000},"content-version":"vor","delay-in-days":4,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Dermatologic Therapy"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1111\/dth.14643","type":"journal-article","created":{"date-parts":[[2020,12,10]],"date-time":"2020-12-10T19:07:06Z","timestamp":1607627226000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Real life data on the biopsychosocial effects of Adalimumab in the management of hidradenitis suppurativa: A multicenter cross sectional analysis and consideration of a multisystem monitoring approach to follow up"],"prefix":"10.1155","volume":"34","author":[{"given":"Vijaytha","family":"Muralidharan","sequence":"first","affiliation":[{"name":"Sandwell and West Birmingham NHS Trust  West Bromwich UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9395-5935","authenticated-orcid":false,"given":"Pirunthan","family":"Pathmarajah","sequence":"additional","affiliation":[{"name":"Sandwell and West Birmingham NHS Trust  West Bromwich UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Peterknecht","sequence":"additional","affiliation":[{"name":"Sandwell and West Birmingham NHS Trust  West Bromwich UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erma","family":"Qazi","sequence":"additional","affiliation":[{"name":"North Bristol NHS Foundation Trust  Bristol UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Barlow","sequence":"additional","affiliation":[{"name":"Barts Health NHS Trust  London UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivek","family":"Muralidharan","sequence":"additional","affiliation":[{"name":"University of Dundee  Dundee UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony","family":"Abdullah","sequence":"additional","affiliation":[{"name":"Sandwell and West Birmingham NHS Trust  West Bromwich UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bryan","family":"McDonald","sequence":"additional","affiliation":[{"name":"North Bristol NHS Foundation Trust  Bristol UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony","family":"Bewley","sequence":"additional","affiliation":[{"name":"Barts Health NHS Trust  London UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2021,1,5]]},"reference":[{"key":"e_1_2_11_2_1","unstructured":"Resource Impact Report.Adalimumab for treating moderate to severe hidradenitis suppurativa (TA392) Putting NICE guidance into practice;2016."},{"key":"e_1_2_11_3_1","doi-asserted-by":"publisher","DOI":"10.1186\/s41702-019-0052-0"},{"key":"e_1_2_11_4_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.16691"},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-157-12-201212180-00004"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.21037\/atm-20-1028"},{"key":"e_1_2_11_7_1","doi-asserted-by":"publisher","DOI":"10.2147\/CCID.S93619"},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2010.04638.x"},{"key":"e_1_2_11_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2008.11.911"},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2018.05.040"},{"key":"e_1_2_11_11_1","doi-asserted-by":"publisher","DOI":"10.2147\/BTT.S199862"},{"key":"e_1_2_11_12_1","doi-asserted-by":"publisher","DOI":"10.2217\/imt-2018-0090"},{"key":"e_1_2_11_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2007.08372.x"},{"key":"e_1_2_11_14_1","doi-asserted-by":"publisher","DOI":"10.5070\/D3223030360"},{"issue":"2","key":"e_1_2_11_15_1","first-page":"93","article-title":"Drug focus: adalimumab in the treatment of moderate to severe psoriasis","volume":"1","author":"Vena GA","year":"2007","journal-title":"Biol Targets Ther"},{"key":"e_1_2_11_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-017-0488-2"},{"issue":"5","key":"e_1_2_11_17_1","first-page":"AB39","article-title":"Adalimumab improves treatment satisfaction with medication (TS\u2010M) in patients with moderate to severe hidradenitis suppurativa (HS) in a 12\u2010week randomized controlled trial (PIONEER II)","volume":"72","author":"Kim ES","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"e_1_2_11_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajd.13027"},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/ced.14127"},{"key":"e_1_2_11_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/exd.13893"},{"key":"e_1_2_11_21_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8040532"},{"key":"e_1_2_11_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.14997"},{"key":"e_1_2_11_23_1","doi-asserted-by":"publisher","DOI":"10.1517\/14740338.4.4.637"},{"issue":"10","key":"e_1_2_11_24_1","first-page":"1192","article-title":"Adalimumab treatment in women with moderate\u2010to\u2010severe Hidradenitis Suppurativa from the placebo\u2010controlled portion of a phase 2, randomized, double\u2010blind study","volume":"15","author":"Gottlieb A","year":"2016","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_11_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/ced.12351"},{"key":"e_1_2_11_26_1","doi-asserted-by":"publisher","DOI":"10.1159\/000453355"},{"key":"e_1_2_11_27_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11916-017-0647-3"},{"key":"e_1_2_11_28_1","doi-asserted-by":"publisher","DOI":"10.1586\/edm.12.54"}],"container-title":["Dermatologic Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/dth.14643","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/dth.14643","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/dth.14643","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T17:58:21Z","timestamp":1671818301000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/dth.14643"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["10.1111\/dth.14643"],"URL":"https:\/\/doi.org\/10.1111\/dth.14643","archive":["Portico"],"relation":{},"ISSN":["1396-0296","1529-8019"],"issn-type":[{"value":"1396-0296","type":"print"},{"value":"1529-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"2020-11-27","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-03","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-01-05","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}